Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe record presents details of the Cabozantinib study for advanced adrenocortical carcinoma, including eligibility criteria, treatment plan, outcomes, study dates, and German locations. It also indicates an unknown current status, with the last known status listed as active, not recruiting.SummaryDifference49%

- Check18 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0, while the 403 error page remained otherwise unchanged.SummaryDifference0.2%

- Check25 days agoChange DetectedA notice about NIH website terminology changes appears above the ClinicalTrials.gov page. The underlying study record still displays a 403 error.SummaryDifference1%

- Check32 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error, with the header and footer present but the study content not shown. This indicates an access/server issue rather than a substantive update to the page content.SummaryDifference18%

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.